These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 7909337

  • 21. Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson's disease and during ageing in non-Parkinsonian subjects.
    Fornstedt Wallin B.
    J Neural Transm (Vienna); 2024 Mar; 131(3):213-228. PubMed ID: 38238531
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Selectivity of melaninized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interaction.
    Ben-Shachar D, Youdim MB.
    J Neural Transm Suppl; 1990 Mar; 29():251-8. PubMed ID: 2193109
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Oxidative metabolites of 5-S-cysteinylnorepinephrine are irreversible inhibitors of mitochondrial complex I and the alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes: possible implications for neurodegenerative brain disorders.
    Xin W, Shen XM, Li H, Dryhurst G.
    Chem Res Toxicol; 2000 Aug; 13(8):749-60. PubMed ID: 10956063
    [Abstract] [Full Text] [Related]

  • 35. Potential new insights into the molecular mechanisms of methamphetamine-induced neurodegeneration.
    Wrona MZ, Yang Z, Zhang F, Dryhurst G.
    NIDA Res Monogr; 1997 Aug; 173():146-74. PubMed ID: 9260188
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Oxidative stress: a role in the pathogenesis of Parkinson's disease.
    Götz ME, Freyberger A, Riederer P.
    J Neural Transm Suppl; 1990 Aug; 29():241-9. PubMed ID: 2193108
    [Abstract] [Full Text] [Related]

  • 38. The role of iron in senescence of dopaminergic neurons in Parkinson's disease.
    Youdim MB, Riederer P.
    J Neural Transm Suppl; 1993 Aug; 40():57-67. PubMed ID: 8294901
    [Abstract] [Full Text] [Related]

  • 39. The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis.
    Enochs WS, Sarna T, Zecca L, Riley PA, Swartz HM.
    J Neural Transm Park Dis Dement Sect; 1994 Aug; 7(2):83-100. PubMed ID: 7710667
    [Abstract] [Full Text] [Related]

  • 40. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.
    Hirsch E, Graybiel AM, Agid YA.
    Nature; 1988 Jul 28; 334(6180):345-8. PubMed ID: 2899295
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.